Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial Alice C. WeiFang-Shu OuMitchell C. Posner Pancreatic Tumors 15 August 2019 Pages: 4489 - 4497
A Prospective, Open-Label, Multicenter Phase 2 Trial of Neoadjuvant Therapy Using Full-Dose Gemcitabine and S-1 Concurrent with Radiation for Resectable Pancreatic Ductal Adenocarcinoma Hidetoshi EguchiYutaka TakedaYuichiro Doki Pancreatic Tumors 22 August 2019 Pages: 4498 - 4505
MiR-194-5p in Pancreatic Ductal Adenocarcinoma Peritoneal Washings is Associated with Peritoneal Recurrence and Overall Survival in Peritoneal Cytology-Negative Patients Hirokazu KuboYukihiko HiroshimaItaru Endo Pancreatic Tumors 05 September 2019 Pages: 4506 - 4514
Management of Acute Cholecystitis during Neoadjuvant Therapy in Patients with Pancreatic Adenocarcinoma Neil R. JariwallaAbdul H. KhanSusan Tsai Pancreatic Tumors 22 October 2019 Pages: 4515 - 4521
Accuracy of Fukuoka and American Gastroenterological Association Guidelines for Predicting Advanced Neoplasia in Pancreatic Cyst Neoplasm: A Meta-Analysis Jiayuan WuYufeng WangHuilai Miao Pancreatic Tumors 15 October 2019 Pages: 4522 - 4536
Preoperative Radiomic Approach to Evaluate Tumor-Infiltrating CD8+ T Cells in Hepatocellular Carcinoma Patients Using Contrast-Enhanced Computed Tomography Haotian LiaoZhen ZhangYong Zeng Hepatobiliary Tumors 13 September 2019 Pages: 4537 - 4547
Severe Preoperative Symptoms Delay Readiness to Return to Intended Oncologic Therapy (RIOT) After Liver Resection Heather A. LillemoeRebecca K. MarcusThomas A. Aloia Hepatobiliary Tumors 14 August 2019 Pages: 4548 - 4555
Prognostic Relevance of a Complete Pathologic Response in Liver Transplantation for Hepatocellular Carcinoma Michał GrątMarek KrawczykKrzysztof Zieniewicz Hepatobiliary Tumors Open access 13 September 2019 Pages: 4556 - 4565
The Achievement of a Sustained Virological Response Either Before or After Hepatectomy Improves the Prognosis of Patients with Primary Hepatitis C Virus-Related Hepatocellular Carcinoma Yukiyasu OkamuraTeiichi SugiuraKatsuhiko Uesaka Hepatobiliary Tumors 10 October 2019 Pages: 4566 - 4575
Laparoscopic Parenchymal-Sparing Hepatectomy for Multiple Colorectal Liver Metastases Improves Outcomes and Salvageability: A Propensity Score-Matched Analysis Shinya OkumuraNicolas TabchouriDavid Fuks Hepatobiliary Tumors 11 October 2019 Pages: 4576 - 4586
Prediction of Histopathologic Growth Patterns of Colorectal Liver Metastases with a Noninvasive Imaging Method Jin ChengJingwei WeiYi Wang Hepatobiliary Tumors 11 October 2019 Pages: 4587 - 4598
Adjuvant Hepatic Arterial Infusion Pump Chemotherapy After Resection of Colorectal Liver Metastases: Results of a Safety and Feasibility Study in The Netherlands Florian E. BuismanDirk J. GrünhagenBas Groot Koerkamp Hepatobiliary Tumors Open access 22 October 2019 Pages: 4599 - 4607
Pure Laparoscopic Anatomic Resection of the Segment 8 Ventral Area Using the Transfissural Glissonean Approach Ji Hoon KimHyeyoung Kim Hepatobiliary Tumors 03 October 2019 Pages: 4608 - 4609
Impact of Effective Systemic Therapy on Metastasectomy in Stage IV Melanoma: A Matched-Pair Analysis Daniel W. NelsonTrevan D. FischerMark B. Faries Melanoma 10 June 2019 Pages: 4610 - 4618
ASO Author Reflections: What Role Do Surgeons Play in the Era of Effective Systemic Therapy for Melanoma? Daniel W. NelsonMark B. Faries ASO Author Reflections 17 September 2019 Pages: 4619 - 4620
Survival Outcomes of Patients with Clinical Stage III Melanoma in the Era of Novel Systemic Therapies Yun SongAndrew D. TieniberGiorgos C. Karakousis Melanoma 03 July 2019 Pages: 4621 - 4630
ASO Author Reflections: Survival for Stage III Melanoma—Where Do We Stand in the Current Landscape of Melanoma Therapies? Yun SongGiorgos C. Karakousis ASO Author Reflections 01 October 2019 Pages: 4631 - 4632
Efficacy of Talimogene Laherparepvec (T-VEC) Therapy in Patients with In-Transit Melanoma Metastasis Decreases with Increasing Lesion Size Sabran J. MasoudJanice B. HuPaul J. Mosca Melanoma 14 August 2019 Pages: 4633 - 4641
Squamous Cell Carcinoma with Regional Metastasis to Axilla or Groin Lymph Nodes: a Multicenter Outcome Analysis George PangNicole J. Look HongFrances C. Wright Melanoma 22 August 2019 Pages: 4642 - 4650
Practice Patterns and Prognostic Value of Sentinel Lymph Node Biopsy for Thick Melanoma: A National Cancer Database Study Yun SongFeredun S. AzariGiorgos C. Karakousis Melanoma 04 September 2019 Pages: 4651 - 4662
Inguinal and Ilio-inguinal Lymphadenectomy in Management of Palpable Melanoma Lymph Node Metastasis: A Long-Term Prospective Evaluation of Morbidity and Quality of Life Michael A. HendersonD. GyorkiJ. F. Thompson Melanoma 12 September 2019 Pages: 4663 - 4672
The Prognosis and Natural History of In-Transit Melanoma Metastases at a High-Volume Centre Emilia Nan TieLumine H. NaDavid E. Gyorki Melanoma 22 October 2019 Pages: 4673 - 4680
Postoperative Cancer Surveillance Following Oncoplastic Surgery with Latissimus Dorsi Flap: a Matched Case–Control Study Kenneth L. FanSimon YangDong Won Lee Reconstructive Oncology 11 October 2019 Pages: 4681 - 4691
Early and Late Complications of Percutaneous Core Needle Biopsy of Retroperitoneal Tumors at Two Tertiary Sarcoma Centers David Berger-RichardsonSally M. BurtenshawCarol J. Swallow Sarcoma 01 August 2019 Pages: 4692 - 4698
Outcome of Primary Desmoid Tumors at All Anatomic Locations Initially Managed with Active Surveillance Winan J. van HoudtOlga HussonWinette T. A. van der Graaf Sarcoma 17 September 2019 Pages: 4699 - 4706
Functional Outcome Measurement in Patients with Lower-Extremity Soft Tissue Sarcoma: A Systematic Literature Review Gilber KaskIan Barner-RasmussenErkki Juhani Tukiainen Sarcoma Open access 12 August 2019 Pages: 4707 - 4722
The Prognostic Value of Lymphovascular Invasion in Truncal and Extremity Soft Tissue Sarcomas: An Analysis from the National Cancer Database Cecilia G. EthunAlexandra G. Lopez-AguiarKenneth Cardona Sarcoma 09 September 2019 Pages: 4723 - 4729
Is Peritoneal Tumor Penetration of Prognostic Importance in Gastrointestinal Stromal Tumors? T. HølmebakkB. BjerkehagenK. Boye Sarcoma 13 September 2019 Pages: 4730 - 4736
Clinical Implications of Conversion Surgery After Induction Therapy for T4b Thoracic Esophageal Squamous Cell Carcinoma Hiroshi MiyataKeijirou SugimuraMasahiko Yano Thoracic Oncology 14 August 2019 Pages: 4737 - 4743
The Influence of the Perioperative Nutritional Status on the Survival Outcomes for Esophageal Cancer Patients with Neoadjuvant Chemotherapy Makoto HikageYusuke TaniyamaTakashi Kamei Thoracic Oncology 22 August 2019 Pages: 4744 - 4753
Dysphagia Score as a Predictor of Adverse Events Due to Triplet Chemotherapy and Oncological Outcomes in 434 Consecutive Patients with Esophageal Cancer Takaomi HagiTomoki MakinoYuichiro Doki Thoracic Oncology 26 August 2019 Pages: 4754 - 4764
Quality of Life During and After Completion of Neoadjuvant Chemoradiotherapy for Esophageal and Junctional Cancer B. J. NoordmanM. G. E. VerdamJ. J. B. van Lanschot Thoracic Oncology Open access 16 October 2019 Pages: 4765 - 4772
Modified Systemic Inflammation Score is Useful for Risk Stratification After Radical Resection of Squamous Cell Carcinoma of the Esophagus Mitsuro KandaMasahiko KoikeYasuhiro Kodera Thoracic Oncology 11 October 2019 Pages: 4773 - 4781
Development of a Novel Humanized Monoclonal Antibody to Secreted Frizzled-Related Protein-2 That Inhibits Triple-Negative Breast Cancer and Angiosarcoma Growth In Vivo Denise GarciaPatrick NasarreNancy Klauber-DeMore Translational Research and Biomarkers 12 September 2019 Pages: 4782 - 4790
Vimentin Expression in Tumor Microenvironment Predicts Survival in Pancreatic Ductal Adenocarcinoma: Heterogeneity in Fibroblast Population Hiromitsu MaehiraToru MiyakeMasaji Tani Translational Research and Biomarkers 03 October 2019 Pages: 4791 - 4804
Association Between Preoperative Muscle Mass and Intraoperative Bacterial Translocation in Patients Undergoing Hepatectomy, Pancreatoduodenectomy, and Esophagectomy Kumiko AkashiYukihiro YokoyamaMasato Nagino Translational Research and Biomarkers 12 August 2019 Pages: 4805 - 4813
Comprehensive Exploration to Identify Predictive DNA Markers of ΔNp63/SOX2 in Drug Resistance in Human Esophageal Squamous Cell Carcinoma Yosuke OoizumiKeita KojimaKeishi Yamashita Translational Research and Biomarkers 16 September 2019 Pages: 4814 - 4825
WiNTRLINC1/ASCL2/c-Myc Axis Characteristics of Colon Cancer with Differentiated Histology at Young Onset and Essential for Cell Viability Kazuko YokotaYoko TanakaKeishi Yamashita Translational Research and Biomarkers 23 September 2019 Pages: 4826 - 4834
Gains of Chromosome 1p and 15q are Associated with Poor Survival After Cytoreductive Surgery and HIPEC for Treating Colorectal Peritoneal Metastases Malin EnbladWilhelm GrafHelgi Birgisson Translational Research and Biomarkers Open access 16 October 2019 Pages: 4835 - 4842